Loading…
← CockpitCompetitor Analysis › 603231.SS Solbar Ningbo Protein Technology Co., Ltd. Class AOpen in the cockpit ↗

Solbar Ningbo Protein Technology Co., Ltd. Class A603231.SSCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Agricultural Commodities/Milling
Momentum leader 91
Mkt cap
$493M
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$3.87M
20-day average traded
Fwd P/E
14.8×
forward earnings
ROIC−WACC
+4.8 pp
WACC 7.6%
Hurdle
n/a
no reverse DCF
Next earnings
164 days
19 Apr 2027
Close · CNYCN¥17.18
1D-1.1%
1W+2.9%
1M+0.8%
3M+14.4%
6M+0.5%
YTD-6.2%
1Y-12.6%
ATR %2.3%
52w lowhigh23.2% off high

What Solbar Ningbo Protein Technology does

Employees: 947

Solbar Ningbo Protein Technology at a glance

Size Solbar Ningbo Protein Technology (603231.SS) is a China Consumer Staples company (Agricultural Commodities/Milling) with a market value of $493M, the 3894th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥17.18 on 6 Nov 2026.

Performance Over six months the shares gained 0.5%, against -8.2% for the median peer and -16.4% for the China market (cap-weighted) — 7th highest of 21 in its peer set.

Growth Revenue grew 19.8% over the last twelve months (peer median -0.4%); the operating margin is 8.3% (peer median 0.4%).

Valuation It trades at 14.8× forward earnings against a peer median of 9.7× (3rd most expensive of 9).

Capital Return on invested capital runs 4.8 points above its cost of capital (7.6% WACC).

Next results Next results expected around 19 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010011 May 202611 Aug 20266 Nov 2026603231.SS 100Peer median 91
Six months, rebased to 100: Solbar Ningbo Protein Technology against the median of its 20 peers (local-currency closes).

Solbar Ningbo Protein Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.96BCN¥1.75BCN¥1.55BCN¥1.75BCN¥1.85B
Revenue growth—+12%-11%-5%—
Gross profitCN¥317MCN¥282MCN¥177MCN¥230MCN¥239M
EBITDAn/aCN¥290MCN¥188MCN¥227MCN¥230M
Net incomeCN¥143MCN¥190MCN¥121MCN¥146MCN¥168M
Free cash flow-CN¥50.7MCN¥134M-CN¥10.0MCN¥44.6MCN¥42.4M
Capital expenditureCN¥215MCN¥190MCN¥169MCN¥99.7MCN¥144M
Total debtCN¥197MCN¥27.1MCN¥31.7MCN¥89.9MCN¥91.3M

Quarterly statements and history in the cockpit →

Solbar Ningbo Protein Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%-10%0%+10%3000946036686004672613000798BAJAJHIND002329FFARM301116600371967626122117300967TLRYING002696002548603231.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Solbar Ningbo Protein Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×6036682613FFARM3011169676TRIVENIING002548603231.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Solbar Ningbo Protein Technology is the large dot.

Solbar Ningbo Protein Technology competitors and peer comparison

How Solbar Ningbo Protein Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Solbar Ningbo Protein Technology against its 20 peers (data as of 6 Nov 2026)
Measure603231.SSPeer medianRank in peer set
1-month return+0.8%-3.7%7th highest of 21
6-month return+0.5%-8.2%7th highest of 21
Distance from 52-week high-23.2%-30.7%7th highest of 21
Revenue growth (TTM)+19.8%-0.4%3rd highest of 21
Operating margin8.3%0.4%4th highest of 21
Forward P/E14.8×9.7×3rd most expensive of 9
ROIC minus cost of capital+4.8 pp-2.7 pp3rd highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Solbar Ningbo Protein Technology 603231.SSChina$493M+1%+20%8%14.8×n/an/a
Zhanjiang Guolian Aquatic Products 300094.SZChina$490M-8%-9%-28%n/a0.7%-6.6%
Fujian Tianma Science & Technology 603668.SSChina$488M-52%+6%-1%4.6×29.6%+10.5%
Shandong Homey Aquatic Development 600467.SSChina$486M-9%-21%14%n/a5.0%-3.1%
J-Oil Mills 2613.TJapan$474M+15%+1%2%16.1×n/an/a
CNFC Overseas Fisheries 000798.SZChina$470M-8%-2%-2%n/an/an/a
Bajaj Hindusthan Sugar BAJAJHIND.NSIndia$470M-8%-2%1%n/an/an/a
Royal 002329.SZChina$467M-15%-2%-25%n/an/an/a
ForFarmers FFARM.ASNetherlands$537M-18%+7%3%8.2×-9.9%+6.0%
Jiangsu Yike Food 301116.SZChina$538M-28%+6%0%42.0×n/an/a
Wanxiang Doneed 600371.SSChina$544M+41%-13%-11%n/an/an/a
Shiyue Daotian 9676.HKHong Kong$545M-35%+26%7%8.4×n/an/a
Kadoya Sesame Mills 2612.TJapan$550M+94%-2%10%n/a0.9%+5.0%
WELLNEO SUGAR 2117.TJapan$555M+2%+8%10%n/a-10.2%+20.9%
Ningxia Xiaoming Agriculture & Animal Husbandry 300967.SZChina$435M-7%-17%-2%n/a21.1%+17.7%
Triveni Engineering and Industries TRIVENI.NSIndia$561M-4%+2%8%11.0×n/an/a
Tilray Brands TLRY.TOCanada$433M-47%+17%-6%n/an/an/a
Inghams ING.AXAustralia$563M+13%+2%4%12.7×-1.2%+3.9%
Baiyang Investment 002696.SZChina$569M+62%+25%0%n/an/an/a
Shenzhen Kingsino Technology 002548.SZChina$428M-35%-2%-12%8.2×12.6%+3.2%
Bannari Amman Sugars BANARISUG.NSIndia$423M-13%-8%6%n/a26.7%+4.9%

Questions

Which companies are Solbar Ningbo Protein Technology's closest peers?
The cockpit's peer set: Zhanjiang Guolian Aquatic Products (300094.SZ), Fujian Tianma Science & Technology (603668.SS), Shandong Homey Aquatic Development (600467.SS), J-Oil Mills (2613.T), CNFC Overseas Fisheries (000798.SZ), Bajaj Hindusthan Sugar (BAJAJHIND.NS), Royal (002329.SZ), ForFarmers (FFARM.AS).
Is Solbar Ningbo Protein Technology expensive compared with its peers?
On forward p/e it trades at 14.8× against a peer median of 9.7×, 3rd most expensive of 9 in its peer set.
How has Solbar Ningbo Protein Technology stock performed?
Over six months to 6 Nov 2026 the shares returned +0.5% against -8.2% for the median peer; over one year -12.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.